Ca2+ channel inhibition induced by nitric oxide in rat insulinoma RINm5F cells

Pflugers Arch. 1999 Jan;437(2):241-7. doi: 10.1007/s004240050775.

Abstract

The effect of nitric oxide (NO) donors on high-voltage-activated Ca2+ channels in insulin-secreting RINm5F cells was investigated using the patch-clamp technique in the whole-cell configuration. Sodium nitroprusside (SNP, 2-400 microM) induced a dose-dependent reduction in Ba2+ currents with maximal inhibition of 58%. The IC50 for SNP was 45 microM. A different NO donor, (+/-)S-nitroso-N-acetylpenicillamine (SNAP, 500 microM), also produced a 50% decrease in current amplitude. When 200 microM SNP was administered together with the NO scavenger 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidozoline-1-oxyl-3-oxide (carboxy-PTIO, 300 microM), the Ba2+ current inhibition was lowered to 7%. Administration of 500 microM 8-bromoguanosine 3':5'-cyclic monophosphate sodium salt (8-Br-cGMP) mimicked the effects of SNP, causing a comparable decrease (56%) in peak-current amplitude. When soluble guanylyl cyclase was blocked by 10 microM 1H-[1,2, 4]oxadiazole[4,3-a]quinoxalin-1-one (ODQ), the inhibitory effect of 200 microM SNP was reduced from 39% to 15%. The SNP-induced current decrease was 36% of controls after the blockade of L-type Ca2+ channels and 30% in the presence of 2.5 microM omega-conotoxin-MVIIC. These data indicate that NO inhibits both L-type and P/Q-type Ca2+ channels in RINm5F cells, probably by an increase in the intracellular levels of cGMP. NO may then significantly influence the Ca2+-dependent release of hormones from secretory cells as well as that of neurotransmitters from nerve terminals.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium Channel Blockers / pharmacology*
  • Calcium Channels / drug effects
  • Calcium Channels / metabolism*
  • Cyclic GMP / physiology
  • Electrophysiology
  • Enzyme Inhibitors / pharmacology
  • Insulinoma / metabolism*
  • Membrane Potentials / physiology
  • Nitric Oxide / pharmacology*
  • Pancreatic Neoplasms / metabolism*
  • Patch-Clamp Techniques
  • Penicillamine / analogs & derivatives
  • Penicillamine / pharmacology
  • Rats
  • S-Nitroso-N-Acetylpenicillamine
  • Sodium-Potassium-Exchanging ATPase / antagonists & inhibitors
  • Tumor Cells, Cultured

Substances

  • Calcium Channel Blockers
  • Calcium Channels
  • Enzyme Inhibitors
  • Nitric Oxide
  • S-Nitroso-N-Acetylpenicillamine
  • Sodium-Potassium-Exchanging ATPase
  • Penicillamine
  • Cyclic GMP